NCT05181189View on ClinicalTrials.gov

NMDA Enhancement Combined With Omega-3 for Early Dementia

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Omega 3 Fatty AcidsDementia
Interventions
DRUG

DAOIB+Omega-3

The omega-3 fatty acids dose will be adjusted every 8 weeks according to clinical evaluation.

DRUG

DAOIB+Placebo

Placebo

Trial Locations (1)

886

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER